@article{article, title  = {{9341 CHAMPAIN Study: Initial results from a phase II study of efficacy, safety and tolerability of modified-release hydrocortisones: Chronocort® (Efmody®) versus Plenadren®, in primary adrenal insufficiency}},

 publisher = {{The Endocrine Society}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/218069 }},

 year = {{2024}},

 month = {{10}},

 author = {{Prete A and Theiler-Schwetz V and Arlt W and Chifu IO and Harbeck B and Napier C and Newell-Price JD and Rees A and Reisch N and Stalla GK and Aslam N et al}},

 doi = {{10.1210/jendso/bvae163.131}},

 volume = {{8}},

 journal = {{Journal of the Endocrine Society}},

 issue = {{Supplement_1}},

 note = {{Accessed on 2025/12/05}}}